Progression-Free Survival: Does a Correlation With Survival Justify Its Role as a Surrogate Clinical Endpoint?

被引：4
作者：
Becker, Andreas [1 ,2 ]
Eichelberg, Christian [1 ]
Sun, Maxine [3 ]
机构：
[1] Univ Hosp Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany
[2] Prostate Canc Ctr, Martini Clin, Hamburg, Germany
[3] Univ Montreal, Ctr Hlth, Dept Urol, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
来源：
CANCER | 2014年 / 120卷 / 01期
关键词：
RENAL-CELL CARCINOMA; BLIND PHASE-III; INTERFERON-ALPHA; CANCER; BIOMARKERS; EVEROLIMUS; SORAFENIB; PREDICTOR; SUNITINIB; PAZOPANIB;
D O I：
10.1002/cncr.28378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this editorial, the authors critically discuss the current role and limitations of progression-free survival as a surrogate endpoint of overall survival in clinical trials.
引用
收藏
页码：7 / 10
页数：4
相关论文
共 30 条
[21]   SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA [J].
PRENTICE, RL .
STATISTICS IN MEDICINE, 1989, 8 (04) :431-440
[22]   Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial [J].
Rini, Brian I. ;
Escudier, Bernard ;
Tomczak, Piotr ;
Kaprin, Andrey ;
Szczylik, Cezary ;
Hutson, Thomas E. ;
Michaelson, M. Dror ;
Gorbunova, Vera A. ;
Gore, Martin E. ;
Rusakov, Igor G. ;
Negrier, Sylvie ;
Ou, Yen-Chuan ;
Castellano, Daniel ;
Lim, Ho Yeong ;
Uemura, Hirotsugu ;
Tarazi, Jamal ;
Cella, David ;
Chen, Connie ;
Rosbrook, Brad ;
Kim, Sinil ;
Motzer, Robert J. .
LANCET, 2011, 378 (9807) :1931-1939
[23]   Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206 [J].
Rini, Brian I. ;
Halabi, Susan ;
Rosenberg, Jonathan E. ;
Stadler, Walter M. ;
Vaena, Daniel A. ;
Archer, Laura ;
Atkins, James N. ;
Picus, Joel ;
Czaykowski, Piotr ;
Dutcher, Janice ;
Small, Eric J. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2137-2143
[24]   Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 [J].
Rini, Brian I. ;
Halabi, Susan ;
Rosenberg, Jonathan E. ;
Stadler, Walter M. ;
Vaena, Daniel A. ;
Ou, San-San ;
Archer, Laura ;
Atkins, James N. ;
Picus, Joel ;
Czaykowski, Piotr ;
Dutcher, Janice ;
Small, Eric J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) :5422-5428
[25]   Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials [J].
Sargent, DJ ;
Wieand, HS ;
Haller, DG ;
Gray, R ;
Benedetti, JK ;
Buyse, M ;
Labianca, R ;
Seitz, JF ;
O'Callaghan, CJ ;
Francini, G ;
Grothey, A ;
O'Connell, M ;
Catalano, PJ ;
Blanke, CD ;
Kerr, D ;
Green, E ;
Wolmark, N ;
Andre, T ;
Goldberg, RM ;
De Gramont, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8664-8670
[26]   Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007 [J].
Sridhara, Rajeshwari ;
Johnson, John R. ;
Justice, Robert ;
Keegan, Patricia ;
Chakravarty, Aloka ;
Pazdur, Richard .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (04) :230-243
[27]   A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update [J].
Sternberg, Cora N. ;
Hawkins, Robert E. ;
Wagstaff, John ;
Salman, Pamela ;
Mardiak, Jozef ;
Barrios, Carlos H. ;
Zarba, Juan J. ;
Gladkov, Oleg A. ;
Lee, Eunsik ;
Szczylik, Cezary ;
McCann, Lauren ;
Rubin, Stephen D. ;
Chen, Mei ;
Davis, Ian D. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1287-1296
[28]   Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial [J].
Sternberg, Cora N. ;
Davis, Ian D. ;
Mardiak, Jozef ;
Szczylik, Cezary ;
Lee, Eunsik ;
Wagstaff, John ;
Barrios, Carlos H. ;
Salman, Pamela ;
Gladkov, Oleg A. ;
Kavina, Alexander ;
Zarba, Juan J. ;
Chen, Mei ;
McCann, Lauren ;
Pandite, Lini ;
Roychowdhury, Debasish F. ;
Hawkins, Robert E. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) :1061-1068
[29]  
Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
[30]   Statistical evaluation of biomarkers as surrogate endpoints: a literature review [J].
Weir, CJ ;
Walley, RJ .
STATISTICS IN MEDICINE, 2006, 25 (02) :183-203
123